FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to medicine, more specifically to (3,5-dimethyl-4-hydroxy)benzylthiododecane of formula .
EFFECT: compound shows anticancer, membrane-stabilising, cytoprotective activity and may be used for reducing cytotoxic effects in tissues accompanying toxic hepatitis, anticancer chemotherapy and with underlying paraneoplastic processes caused by malignant growth.
10 ex, 7 tbl, 3 dwg
Title | Year | Author | Number |
---|---|---|---|
CORRECTOR OF CYTOSTATIC POLYCHEMOTHERAPY | 2007 |
|
RU2353623C1 |
CORRECTIVE AGENT FOR PARANEOPLASTIC DAMAGES AND TOXIC EFFECTS OF CYTOSTATIC POLYCHEMOTHERAPY | 2008 |
|
RU2385324C1 |
N-[3-OXO-LUPANO-28-YL]-PIPERIDINE - AGENT HAVING ANTI-TUMOUR, ANTI-METASTATIC, ANTI-INFLAMMATORY AND CYTOPROTECTIVE ACTIVITY | 2011 |
|
RU2466136C1 |
N-[3-OXO-LUPANO-28-YL]-MORPHOLINE - AGENT FOR CORRECTION OF CYTOTOXIC LIVER DAMAGES WITH ANTITUMOUR AND ANTIMETASTATIC ACTIVITY | 2011 |
|
RU2461563C1 |
AGENT FOR CORRECTION OF CYTOSTATIC POLYCHEMOTHERAPY WITH ANTI-INFLAMMATORY ACTIVITY | 2010 |
|
RU2425680C1 |
ANTI-INFLAMMATORY AND ANTINEOPLASTIC ANTICOAGULANT | 2009 |
|
RU2408379C2 |
ANTI-INFLAMMATORY MEDICATION WITH ANTICOAGULANT, ANTITUMOUR AND ANTIMETASTETIC ACTIVITY | 2009 |
|
RU2412712C1 |
N,N'((ALKANDIYL)BIS[LABDA-7(9),13,14-TRIENE-4-CARBOXAMIDES] WITH ANTITUMOUR ACTIVITY | 2017 |
|
RU2654201C1 |
(Z)-METHYL-16-(5-OXO-2-PHENYL-OXAZOL-4-ILIDENMETHYL)-15,16-EPOXY-8(17),13(16),14-LABDATRIEN-18-OATE, POSSESSING ANTIOXIDATIVE, HEPATOPROTECTIVE AND HEMOSTIMULATING ACTIVITY | 2007 |
|
RU2353620C1 |
AGENT FOR TREATING OSTEOMYELITIS | 2015 |
|
RU2604124C1 |
Authors
Dates
2012-04-20—Published
2011-04-11—Filed